REFERENCES ........................................................................................................................ 81 TABLE OF TABLES Table 1: Schedule of visits ................................................................................................. 38 Table 2: Schedule of visits – Concomitant group ............................................................... 40 Table 3: Schedule of visits – Modif ied vaccination group ................................................. 42 Table 4: Gemcitabine dose delay/reduction guidelines ...................................................... 57 Table 5: Summary of required laboratory assessm ents ......................................................